ArticlemedRxiv : the preprint server for health sciences2026
Predicting Hospice Use Among American Indian/Alaska Native Persons with End-Stage Kidney Disease.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: American Indian/Alaska Native individuals are disproportionately affected by end-stage kidney disease. Once diagnosed, treatment options include receiving a kidney transplant or starting dialysis. Disparities in treatment options are linked to social determinants of health, and in rural areas, dialysis is often the preferred treatment due to limited access to transplant. A recent nationwide analysis of survival differences showed a survival advantage after starting dialysis but also found that patients in these populations are less likely to receive hospice care before death. They face early diagnosis, leading to more years on dialysis and reduced quality of life. Using a predictive model can help identify factors that affect hospice use among patients. This study proposes a predictive model to estimate the likelihood of hospice use before death among patients who received a kidney transplant. Methods: Using the 2022 USRDS Standard Analysis Files, adults who fit inclusion criteria were retrospectively identified. Area Deprivation Index (ADI) data, used for this analysis, includes 17 variables from US Census data, such as income, education, housing security, employment, and healthcare access, to generate the standardized ranking. This study employed regression tree, random forest, boosting, and support vector machine techniques to predict hospice use among participants. The covariates used in this study are race, IHS region, age, sex, mean ADI, comorbidities, and transplant status. Models are assessed based on their predictive performance using accuracy, sensitivity, and specificity. Results: The random forest model outperforms others in accuracy, boosting offers the best sensitivity, and support vector machine and random forest excel in specificity. Overall, random forest and boosting are top models, with logistic regression as second-best. Logistic regression provides more interpretable results. The results, however, suggest a nonlinear relationship between covariates and the response that logistic regression might not capture. Based on both metrics, IHS region, age, and ADI are the most important features. Conclusions: Including measures like the ADI in predictive models highlights geographic disparities that are often overlooked and can guide interventions toward communities that have been historically underserved. Researchers and healthcare systems should improve access to hospice and palliative care for those who face these disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.